<DOC>
	<DOCNO>NCT02428998</DOCNO>
	<brief_summary>Korean Red Ginseng appear adverse event adult take 24 week Placebo comparative assessment . And exploratory Korean Red Ginseng blood sugar control , reduce body fat , URTI prevention , cardiovascular risk , renal function , cholesterol , improve , fatigue , determine impact biological age .</brief_summary>
	<brief_title>Safety 24 Weeks Intake Korean Red Ginseng Adults</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>1 . 19 year old 2. agree participate test , voluntarily sign party write agreement 3 . In case woman childbearing age confirm negative pregnancy test , agree contraception trial period apply human character 1 . Pregnant lactate mother 2 . Patients history hypersensitivity contain ingredient cause test food 3. patient severe renal disease ( serum creatinine level great 1.5 time upper limit normal 4 . Patients severe hepatic disease , cirrhosis ( AST ALT great three time upper limit normal ) 5. autoimmune disease ( multiple sclerosis , lupus , rheumatoid arthritis , etc . ) patient 6. patient uncontrolled diabetes ( HbA1c 8.0 % ) 7 . Sulphonylureas , diabetic patient treat Insulin 8. , uncontrolled hypertension ( systolic blood pressure 150mmHg high diastolic blood pressure great 100mmHg ) 9. uncontrolled hyperlipidemia patient ( LDLcholesterol 160mg / dL high ) 10. patient uncontrolled thyroid dysfunction 11. patient dementia psychiatric problem 12. treat systemic steroid screen visit within 1 week ago 13. screen visit 4 week continuously two week , mentally ill insomnia patient receive antipsychotic medication within 14. take medicine within 4 week screen visit 15. take investigational drug human test food application within four week screen visit 16. take health supplement vitamins mineral within 2 week randomization 17. mean clinical care âˆ™ Psychiatric Disorders disease , cardiovascular disease , gastrointestinal disease , malignant tumor medical condition likely affect test result determine unfit test patient participation</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>